New Jersey A 4273: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2018-06-27)

State: New Jersey · Session: 218 · Bill: A 4273

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Conaway, Herb, Pinkin, Nancy J.

View New Jersey A 4273 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.